Not Rated
|
Fund Size
(0.06% of Investment in Category)
|
Expense Ratio
(0.89% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 24-Nov-25 | 10056.40 | 0.56% | - | 1.04% | 176/229 |
| 1 Month | 31-Oct-25 | 10027.10 | 0.27% | - | 0.42% | 114/229 |
| 3 Month | 01-Sep-25 | 10215.70 | 2.16% | - | 4.22% | 169/226 |
| 6 Month | 30-May-25 | 10537.80 | 5.38% | - | 6.29% | 119/215 |
| YTD | 01-Jan-25 | 9893.10 | -1.07% | - | 5.70% | 157/201 |
| Since Inception | 27-Dec-24 | 9993.00 | -0.07% | -0.08% | 14.13% | 187/201 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| No Data Found | |||||
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Divis Laboratories Ltd. | Pharmaceuticals | 296 | 8.81% | 1.06% | 9.27% (Apr 2025) | 0% (Nov 2024) | 43.94 k | 0.00 |
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 257.4 | 7.66% | 0.13% | 8.83% (Apr 2025) | 0% (Nov 2024) | 1.52 L | 0.00 |
| Apollo Hospitals Enterprises Ltd. | Hospital | 210.1 | 6.26% | -0.03% | 6.29% (Aug 2025) | 0% (Nov 2024) | 27.36 k | 0.00 |
| Cipla Ltd. | Pharmaceuticals | 168 | 5.00% | -0.45% | 8.33% (Apr 2025) | 0% (Nov 2024) | 1.12 L | -4.90 k |
| Neuland Laboratories Ltd. | Pharmaceuticals | 137.4 | 4.09% | 0.31% | 4.09% (Oct 2025) | 0% (Nov 2024) | 8.34 k | 0.00 |
| Biocon Ltd. | Pharmaceuticals | 126.4 | 3.76% | 0.17% | 4.24% (Jan 2025) | 0% (Nov 2024) | 3.40 L | 0.00 |
| Fortis Healthcare Ltd. | Hospital | 123 | 3.66% | -0.17% | 3.83% (Sep 2025) | 0% (Nov 2024) | 1.20 L | -7.23 k |
| Aurobindo Pharma Ltd. : Futures Near | Pharmaceuticals | 116.8 | 3.48% | 0.04% | 3.48% (Oct 2025) | 0% (Nov 2024) | 1.02 L | 0.00 |
| Piramal Pharma Ltd. | Pharmaceuticals | 108.9 | 3.24% | 0.01% | 3.98% (Jan 2025) | 0% (Nov 2024) | 5.45 L | 0.00 |
| Emcure Pharmaceuticals Ltd. | Pharmaceuticals | 108.2 | 3.22% | -0.04% | 3.45% (Aug 2025) | 0% (Nov 2024) | 82.00 k | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 4.38% |
| MF Units | MF Units | 1.49% |
| Net Receivables | Net Receivables | -1.68% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
Out of 19 mutual fund schemes offered by this AMC, 2 is/are ranked 5 * , 1 is/are ranked 3 * , and 16 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Bajaj Finserv Money Market Fund - Direct Plan - Growth | 5 | 6101.32 | 0.53 | 1.53 | 3.29 | 7.71 | 0.00 |
| Bajaj Finserv Flexi Cap Fund - Direct Plan - Growth | NA | 6034.03 | 0.43 | 5.00 | 7.32 | 7.88 | 0.00 |
| Bajaj Finserv Liquid Fund - Direct Plan - Growth | 5 | 5996.06 | 0.48 | 1.45 | 2.96 | 6.67 | 0.00 |
| Bajaj Finserv Large and Mid Cap Fund - Direct Plan - Growth | NA | 2245.16 | 1.67 | 5.21 | 5.70 | 6.16 | 0.00 |
| Bajaj Finserv Large Cap Fund - Direct Plan - Growth | NA | 1666.14 | 1.78 | 6.94 | 6.91 | 7.24 | 0.00 |
| Bajaj Finserv Small Cap Fund - Direct Plan - Growth | NA | 1512.36 | -2.61 | 2.37 | 0.00 | 0.00 | 0.00 |
| Bajaj Finserv Balanced Advantage - Direct Plan - Growth | NA | 1325.24 | 1.71 | 6.50 | 5.94 | 8.78 | 0.00 |
| Bajaj Finserv Multi Asset Allocation Fund - Direct Plan - Growth | NA | 1283.50 | 2.97 | 10.49 | 12.80 | 16.35 | 0.00 |
| Bajaj Finserv Arbitrage Fund - Direct Plan - Growth | 3 | 1256.94 | 0.58 | 1.54 | 3.15 | 6.77 | 0.00 |
| Bajaj Finserv Multi Cap Fund - Direct Plan - Growth | NA | 1022.75 | 0.74 | 4.85 | 4.35 | 0.00 | 0.00 |